Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Science 304 (5674): 1164-1166

Copyright © 2004 by the American Association for the Advancement of Science

Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

Zhenghe Wang,1 Dong Shen,1* D. Williams Parsons,1* Alberto Bardelli,1* Jason Sager,1 Steve Szabo,1 Janine Ptak,1 Natalie Silliman,1 Brock A. Peters,1 Michiel S. van der Heijden,1 Giovanni Parmigiani,1 Hai Yan,2 Tian-Li Wang,1 Greg Riggins,1 Steven M. Powell,3 James K. V. Willson,4 Sanford Markowitz,4 Kenneth W. Kinzler,1 Bert Vogelstein,1 Victor E. Velculescu1{dagger}

Abstract: Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis. A mutational analysis of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers and a smaller fraction of lung, breast, and gastric cancers. Fifteen mutations were nonsense, frameshift, or splice-site alterations predicted to result in truncated proteins lacking phosphatase activity. Five missense mutations in the most commonly altered PTP (PTPRT) were biochemically examined and found to reduce phosphatase activity. Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth. These observations suggest that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.

1 The Sidney Kimmel Comprehensive Cancer Center, The Howard Hughes Medical Institute, The Johns Hopkins University Medical Institutions, Baltimore, MD 21231, USA.
2 Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
3 Division of Gastroenterology/Heptalogy, UVA Health System, Charlottesville, VA 22908, USA.
4 Howard Hughes Medical Institute and Department of Medicine and Ireland Cancer Center, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106, USA

Back to Top

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed: E-mail: velculescu{at}jhmi.edu

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Association Mapping of the High-Grade Myopia MYP3 Locus Reveals Novel Candidates UHRF1BP1L, PTPRR, and PPFIA2.
F. Hawthorne, S. Feng, R. Metlapally, Y.-J. Li, K.-N. Tran-Viet, J. A. Guggenheim, F. Malecaze, P. Calvas, T. Rosenberg, D. A. Mackey, et al. (2013)
Invest. Ophthalmol. Vis. Sci. 54, 2076-2086
   Abstract »    Full Text »    PDF »
PTPN14 is required for the density-dependent control of YAP1.
W. Wang, J. Huang, X. Wang, J. Yuan, X. Li, L. Feng, J.-I. Park, and J. Chen (2012)
Genes & Dev. 26, 1959-1971
   Abstract »    Full Text »    PDF »
Human POLB Gene Is Mutated in High Percentage of Colorectal Tumors.
K. A. Donigan, K.-w. Sun, A. A. Nemec, D. L. Murphy, X. Cong, V. Northrup, D. Zelterman, and J. B. Sweasy (2012)
J. Biol. Chem. 287, 23830-23839
   Abstract »    Full Text »    PDF »
Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project.
C. A. Iacobuzio-Donahue (2012)
Gut 61, 1085-1094
   Abstract »    Full Text »    PDF »
Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
X. Cao, Y. Li, R.-Z. Luo, L.-R. He, J. Yang, M.-S. Zeng, and Z.-S. Wen (2012)
Ann. Thorac. Surg. 93, 1674-1680
   Abstract »    Full Text »    PDF »
Oncogenomics Methods and Resources.
S. J. Furney, G. Gundem, and N. Lopez-Bigas (2012)
Cold Spring Harb Protoc 2012, pdb.top069229
   Abstract »    Full Text »    PDF »
Cross-talk between Phospho-STAT3 and PLC{gamma}1 Plays a Critical Role in Colorectal Tumorigenesis.
P. Zhang, Y. Zhao, X. Zhu, D. Sedwick, X. Zhang, and Z. Wang (2011)
Mol. Cancer Res. 9, 1418-1428
   Abstract »    Full Text »    PDF »
Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'.
G. Lin, V. Aranda, S. K. Muthuswamy, and N. K. Tonks (2011)
Genes & Dev. 25, 1412-1425
   Abstract »    Full Text »    PDF »
Protein Tyrosine Phosphatase Receptor Type {gamma} Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia.
M. Della Peruta, G. Martinelli, E. Moratti, D. Pintani, M. Vezzalini, A. Mafficini, T. Grafone, I. Iacobucci, S. Soverini, M. Murineddu, et al. (2010)
Cancer Res. 70, 8896-8906
   Abstract »    Full Text »    PDF »
Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors.
J. N. Andersen, S. Sathyanarayanan, A. Di Bacco, A. Chi, T. Zhang, A. H. Chen, B. Dolinski, M. Kraus, B. Roberts, W. Arthur, et al. (2010)
Science Translational Medicine 2, 43ra55
   Abstract »    Full Text »    PDF »
Human variation databases.
J. Kuntzer, D. Eggle, S. Klostermann, and H. Burtscher (2010)
Database 2010, baq015
   Abstract »    Full Text »    PDF »
PTPL1/PTPN13 Regulates Breast Cancer Cell Aggressiveness through Direct Inactivation of Src Kinase.
M. Glondu-Lassis, M. Dromard, M. Lacroix-Triki, P. Nirde, C. Puech, D. Knani, D. Chalbos, and G. Freiss (2010)
Cancer Res. 70, 5116-5126
   Abstract »    Full Text »    PDF »
PTPH1 Dephosphorylates and Cooperates with p38{gamma} MAPK to Increase Ras Oncogenesis through PDZ-Mediated Interaction.
S. W. Hou, H. Y. Zhi, N. Pohl, M. Loesch, X. M. Qi, R. S. Li, Z. Basir, and G. Chen (2010)
Cancer Res. 70, 2901-2910
   Abstract »    Full Text »    PDF »
Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T.
Y. Zhao, X. Zhang, K. Guda, E. Lawrence, Q. Sun, T. Watanabe, Y. Iwakura, M. Asano, L. Wei, Z. Yang, et al. (2010)
PNAS 107, 2592-2597
   Abstract »    Full Text »    PDF »
Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.
S. E. Wojcik, S. Rossi, M. Shimizu, M. S. Nicoloso, A. Cimmino, H. Alder, V. Herlea, L. Z. Rassenti, K. R. Rai, T. J. Kipps, et al. (2010)
Carcinogenesis 31, 208-215
   Abstract »    Full Text »    PDF »
Does Detection of Merkel Cell Polyomavirus in Merkel Cell Carcinoma Provide Prognostic Information?.
J. A. DeCaprio (2009)
J Natl Cancer Inst 101, 905-907
   Full Text »    PDF »
Cancer Genome Sequencing--An Interim Analysis.
E. J. Fox, J. J. Salk, and L. A. Loeb (2009)
Cancer Res. 69, 4948-4950
   Abstract »    Full Text »    PDF »
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
S. Veeriah, C. Brennan, S. Meng, B. Singh, J. A. Fagin, D. B. Solit, P. B. Paty, D. Rohle, I. Vivanco, J. Chmielecki, et al. (2009)
PNAS 106, 9435-9440
   Abstract »    Full Text »    PDF »
Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.
Y. Zhang, Y. Tu, J. Zhao, K. Chen, and C. Wu (2009)
J. Cell Biol. 184, 785-792
   Abstract »    Full Text »    PDF »
The Eighth Fibronectin Type III Domain of Protein Tyrosine Phosphatase Receptor J Influences the Formation of Protein Complexes and Cell Localization.
R. Iuliano, C. Raso, A. Quintiero, I. L. Pera, F. Pichiorri, T. Palumbo, D. Palmieri, A. Pattarozzi, T. Florio, G. Viglietto, et al. (2009)
J. Biochem. 145, 377-385
   Abstract »    Full Text »    PDF »
Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma.
D. A. Solomon, J.-S. Kim, J. C. Cronin, Z. Sibenaller, T. Ryken, S. A. Rosenberg, H. Ressom, W. Jean, D. Bigner, H. Yan, et al. (2008)
Cancer Res. 68, 10300-10306
   Abstract »    Full Text »    PDF »
Functional Analysis of a Cell Cycle-Associated, Tumor-Suppressive Gene, Protein Tyrosine Phosphatase Receptor Type G, in Nasopharyngeal Carcinoma.
A. K. L. Cheung, H. L. Lung, S. C. Hung, E. W. L. Law, Y. Cheng, W. L. Yau, D. K. Bangarusamy, L. D. Miller, E. T.-B. Liu, J.-Y. Shao, et al. (2008)
Cancer Res. 68, 8137-8145
   Abstract »    Full Text »    PDF »
Tumor-Derived Extracellular Mutations of PTPRT/PTP{rho} Are Defective in Cell Adhesion.
J. Yu, S. Becka, P. Zhang, X. Zhang, S. M. Brady-Kalnay, and Z. Wang (2008)
Mol. Cancer Res. 6, 1106-1113
   Abstract »    Full Text »    PDF »
Defining the blueprint of the cancer genome.
V. E. Velculescu (2008)
Carcinogenesis 29, 1087-1091
   Abstract »    Full Text »    PDF »
The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth.
W. C. Spanos, A. Hoover, G. F. Harris, S. Wu, G. L. Strand, M. E. Anderson, A. J. Klingelhutz, W. Hendriks, A. D. Bossler, and J. H. Lee (2008)
J. Virol. 82, 2493-2500
   Abstract »    Full Text »    PDF »
Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells.
M. Emaduddin, D. C. Bicknell, W. F. Bodmer, and S. M. Feller (2008)
PNAS 105, 2358-2362
   Abstract »    Full Text »    PDF »
Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses.
S. Topffer, A. Muller-Schiffmann, K. Matentzoglu, M. Scheffner, and G. Steger (2007)
J. Gen. Virol. 88, 2956-2965
   Abstract »    Full Text »    PDF »
Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650).
J. Wang, H. Cao, M. R. Ban, B. A. Kennedy, S. Zhu, S. Anand, S. Yusuf, R. L. Pollex, and R. A. Hegele (2007)
Arterioscler Thromb Vasc Biol 27, 2450-2455
   Abstract »    Full Text »    PDF »
The protein tyrosine phosphatase Pez regulates TGF{beta}, epithelial mesenchymal transition, and organ development.
L. Wyatt, C. Wadham, L. A. Crocker, M. Lardelli, and Y. Khew-Goodall (2007)
J. Cell Biol. 178, 1223-1235
   Abstract »    Full Text »    PDF »
Structure of a Tyrosine Phosphatase Adhesive Interaction Reveals a Spacer-Clamp Mechanism.
A. R. Aricescu, C. Siebold, K. Choudhuri, V. T. Chang, W. Lu, S. J. Davis, P. A. van der Merwe, and E. Y. Jones (2007)
Science 317, 1217-1220
   Abstract »    Full Text »    PDF »
Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten (2007)
Carcinogenesis 28, 1703-1709
   Abstract »    Full Text »    PDF »
The Putative Tumor Suppressor Gene PTPN13/PTPL1 Induces Apoptosis through Insulin Receptor Substrate-1 Dephosphorylation.
M. Dromard, G. Bompard, M. Glondu-Lassis, C. Puech, D. Chalbos, and G. Freiss (2007)
Cancer Res. 67, 6806-6813
   Abstract »    Full Text »    PDF »
Normal TCR Signal Transduction in Mice That Lack Catalytically Active PTPN3 Protein Tyrosine Phosphatase.
T. J. Bauler, E. D. Hughes, Y. Arimura, T. Mustelin, T. L. Saunders, and P. D. King (2007)
J. Immunol. 178, 3680-3687
   Abstract »    Full Text »    PDF »
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.
X. Zhang, A. Guo, J. Yu, A. Possemato, Y. Chen, W. Zheng, R. D. Polakiewicz, K. W. Kinzler, B. Vogelstein, V. E. Velculescu, et al. (2007)
PNAS 104, 4060-4064
   Abstract »    Full Text »    PDF »
Degradation of Tyrosine Phosphatase PTPN3 (PTPH1) by Association with Oncogenic Human Papillomavirus E6 Proteins.
M. Jing, J. Bohl, N. Brimer, M. Kinter, and S. B. Vande Pol (2007)
J. Virol. 81, 2231-2239
   Abstract »    Full Text »    PDF »
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.
R. J. Chan and G.-S. Feng (2007)
Blood 109, 862-867
   Abstract »    Full Text »    PDF »
Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms.
J. S. Kaminker, Y. Zhang, A. Waugh, P. M. Haverty, B. Peters, D. Sebisanovic, J. Stinson, W. F. Forrest, J. F. Bazan, S. Seshagiri, et al. (2007)
Cancer Res. 67, 465-473
   Abstract »    Full Text »    PDF »
Ptpmeg is required for the proper establishment and maintenance of axon projections in the central brain of Drosophila.
J. L. Whited, M. B. Robichaux, J. C. Yang, and P. A. Garrity (2007)
Development 134, 43-53
   Abstract »    Full Text »    PDF »
Human cancers express a mutator phenotype.
J. H. Bielas, K. R. Loeb, B. P. Rubin, L. D. True, and L. A. Loeb (2006)
PNAS 103, 18238-18242
   Abstract »    Full Text »    PDF »
Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs.
M. T. Engelmark, E. L. Ivansson, J. J. Magnusson, I. M. Gustavsson, A. H. Beskow, P. K.E. Magnusson, and U. B. Gyllensten (2006)
Hum. Mol. Genet. 15, 3351-3360
   Abstract »    Full Text »    PDF »
Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway.
E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay (2006)
Am J Physiol Cell Physiol 291, C433-C444
   Abstract »    Full Text »    PDF »
Receptor Protein Tyrosine Phosphatase {gamma} Is a Marker for Pyramidal Cells and Sensory Neurons in the Nervous System and Is Not Necessary for Normal Development.
S. Lamprianou, N. Vacaresse, Y. Suzuki, H. Meziane, J. D. Buxbaum, J. Schlessinger, and S. Harroch (2006)
Mol. Cell. Biol. 26, 5106-5119
   Abstract »    Full Text »    PDF »
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.
A. I. Schafer (2006)
Blood 107, 4214-4222
   Abstract »    Full Text »    PDF »
High-Resolution Analysis of Chromosomal Breakpoints and Genomic Instability Identifies PTPRD as a Candidate Tumor Suppressor Gene in Neuroblastoma..
R. L. Stallings, P. Nair, J. M. Maris, D. Catchpoole, M. McDermott, A. O'Meara, and F. Breatnach (2006)
Cancer Res. 66, 3673-3680
   Abstract »    Full Text »    PDF »
Improving Cancer Gene Screens: Insertional Mutagenesis Using Sleeping Beauty.
D. A. Largaespada (2006)
Am. Assoc. Cancer Res. Educ. Book 2006, 24-28
   Full Text »    PDF »
The epithelial-mesenchymal transition: new insights in signaling, development, and disease..
J. M. Lee, S. Dedhar, R. Kalluri, and E. W. Thompson (2006)
J. Cell Biol. 172, 973-981
   Abstract »    Full Text »    PDF »
Genetic Characterization of Fas-Associated Phosphatase-1 as a Putative Tumor Suppressor Gene on Chromosome 4q21.3 in Hepatocellular Carcinoma.
S.-H. Yeh, D.-C. Wu, C.-Y. Tsai, T.-J. Kuo, W.-C. Yu, Y.-S. Chang, C.-L. Chen, C.-F. Chang, D.-S. Chen, and P.-J. Chen (2006)
Clin. Cancer Res. 12, 1097-1108
   Abstract »    Full Text »    PDF »
Interruption of Homologous Desensitization in Cyclic Guanosine 3',5'-Monophosphate Signaling Restores Colon Cancer Cytostasis by Bacterial Enterotoxins.
G. M. Pitari, R. I. Baksh, D. M. Harris, P. Li, S. Kazerounian, and S. A. Waldman (2005)
Cancer Res. 65, 11129-11135
   Abstract »    Full Text »    PDF »
Identification of an Acquired JAK2 Mutation in Polycythemia Vera.
R. Zhao, S. Xing, Z. Li, X. Fu, Q. Li, S. B. Krantz, and Z. J. Zhao (2005)
J. Biol. Chem. 280, 22788-22792
   Abstract »    Full Text »    PDF »
Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73.
R. van Doorn, W. H. Zoutman, R. Dijkman, R. X. de Menezes, S. Commandeur, A. A. Mulder, P. A. van der Velden, M. H. Vermeer, R. Willemze, P. S. Yan, et al. (2005)
J. Clin. Oncol. 23, 3886-3896
   Abstract »    Full Text »    PDF »
Differential Oxidation of Protein-tyrosine Phosphatases.
A. Groen, S. Lemeer, T. van der Wijk, J. Overvoorde, A. J. R. Heck, A. Ostman, D. Barford, M. Slijper, and J. den Hertog (2005)
J. Biol. Chem. 280, 10298-10304
   Abstract »    Full Text »    PDF »
Crystal Structure of the PTPL1/FAP-1 Human Tyrosine Phosphatase Mutated in Colorectal Cancer: EVIDENCE FOR A SECOND PHOSPHOTYROSINE SUBSTRATE RECOGNITION POCKET.
F. Villa, M. Deak, G. B. Bloomberg, D. R. Alessi, and D. M. F. van Aalten (2005)
J. Biol. Chem. 280, 8180-8187
   Abstract »    Full Text »    PDF »
Drugging the Cancer Kinome: Progress and Challenges in Developing Personalized Molecular Cancer Therapeutics.
P. WORKMAN (2005)
Cold Spring Harb Symp Quant Biol 70, 499-515
   Abstract »    PDF »
Elimination of Hepatic Metastases of Colon Cancer Cells via p53-Independent Cross-Talk between Irinotecan and Apo2 Ligand/TRAIL.
R. Ravi, A. J. Jain, R. D. Schulick, V. Pham, T. S. Prouser, H. Allen, E. G. Mayer, H. Yu, D. M. Pardoll, A. Ashkenazi, et al. (2004)
Cancer Res. 64, 9105-9114
   Abstract »    Full Text »    PDF »
High sensitivity EndoV mutation scanning through real-time ligase proofreading.
H. Pincas, M. R. Pingle, J. Huang, K. Lao, P. B. Paty, A. M. Friedman, and F. Barany (2004)
Nucleic Acids Res. 32, e148
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882